Filings under MDT by Medtronic Inc (CIK 0000064670) from Jan 4, 2001 to Jan 26, 2015 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | Tax withholding(F) | 1K | $92.30 | $100K |
| Aug 3, 2026 | Martha Geoffrey | Chairman and CEO, Director | Grant(A) | 42K | — | $0 |
| Aug 3, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | Grant(A) | 23K | — | $0 |
| Aug 3, 2026 | Pieton Thierry | EVP & Chief Financial Officer | Grant(A) | 12K | — | $0 |
| Aug 3, 2026 | Walter Matthew R. | SVP, Chief HR Officer | Grant(A) | 41K | — | $0 |
| Aug 3, 2026 | Blomquist Denise L. | Chief Accounting Officer | Grant(A) | 2K | — | $0 |
| Aug 3, 2026 | Martha Geoffrey | Chairman and CEO, Director | Grant(A) | 295K | — | $0 |
| Aug 3, 2026 | Thompson Kweli | EVP & President, Neuroscience | Grant(A) | 17K | — | $0 |
| Aug 3, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | Grant(A) | 9K | — | $0 |
| Aug 3, 2026 | Pieton Thierry | EVP & Chief Financial Officer | Grant(A) | 82K | — | $0 |
| Aug 3, 2026 | Quinn Michelle | EVP, GC and Secretary | Grant(A) | 45K | — | $0 |
| Aug 3, 2026 | Walter Matthew R. | SVP, Chief HR Officer | Grant(A) | 14K | — | $0 |
| Aug 3, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | Grant(A) | 66K | — | $0 |
| Aug 3, 2026 | Walter Matthew R. | SVP, Chief HR Officer | Grant(A) | 6K | — | $0 |
| Aug 3, 2026 | Pieton Thierry | EVP & Chief Financial Officer | Grant(A) | 29K | — | $0 |
| Aug 3, 2026 | Quinn Michelle | EVP, GC and Secretary | Grant(A) | 16K | — | $0 |
| Aug 3, 2026 | Thompson Kweli | EVP & President, Neuroscience | Grant(A) | 7K | — | $0 |
| Aug 3, 2026 | Martha Geoffrey | Chairman and CEO, Director | Grant(A) | 104K | — | $0 |
| Aug 3, 2026 | Quinn Michelle | EVP, GC and Secretary | Grant(A) | 6K | — | $0 |
| Aug 3, 2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | Grant(A) | 11K | — | $0 |
| Aug 3, 2026 | Thompson Kweli | EVP & President, Neuroscience | Grant(A) | 49K | — | $0 |
| Aug 3, 2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | Grant(A) | 78K | — | $0 |
| Aug 3, 2026 | Martha Geoffrey | Chairman and CEO, Director | Grant(A) | 273K | — | $0 |
| Aug 3, 2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | Grant(A) | 27K | — | $0 |
| Aug 3, 2026 | Blomquist Denise L. | Chief Accounting Officer | Grant(A) | 1K | — | $0 |
| Aug 3, 2026 | Blomquist Denise L. | Chief Accounting Officer | Grant(A) | 2K | — | $0 |
| Aug 3, 2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | Grant(A) | 46K | — | $0 |
| Jul 31, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | Tax withholding(F) | 3K | $85.39 | $262K |
| Jul 31, 2026 | Martha Geoffrey | Chairman and CEO, Director | Tax withholding(F) | 16K | $85.39 | $1.4M |
| Jul 31, 2026 | Blomquist Denise L. | Chief Accounting Officer | Tax withholding(F) | 212 | $85.39 | $18K |
| Jul 31, 2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | Tax withholding(F) | 3K | $85.39 | $287K |
| Jul 31, 2026 | Thompson Kweli | EVP & President, Neuroscience | Tax withholding(F) | 2K | $85.39 | $148K |
| Jul 31, 2026 | Walter Matthew R. | SVP, Chief HR Officer | Tax withholding(F) | 2K | $85.39 | $143K |
| Jul 28, 2026 | Quinn Michelle | EVP, GC and Secretary | Tax withholding(F) | 2K | $86.88 | $180K |
| Jul 8, 2026 | Walter Matthew R. | SVP, Chief HR Officer | Sell(S) | 3K | $83.15 | $258K |
| Jun 8, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | Sell(S) | 228 | $80.45 | $18K |
| Jun 8, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | Sell(S) | 4K | $80.44 | $319K |
| Jun 5, 2026 | Blomquist Denise L. | Chief Accounting Officer | Tax withholding(F) | 237 | $83.32 | $20K |
| Jun 4, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | Tax withholding(F) | 7K | $83.32 | $568K |
| Jun 4, 2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | Tax withholding(F) | 7K | $83.32 | $622K |
| Jun 4, 2026 | Martha Geoffrey | Chairman and CEO, Director | Tax withholding(F) | 42K | $83.32 | $3.5M |
| Jun 4, 2026 | Walter Matthew R. | SVP, Chief HR Officer | Tax withholding(F) | 3K | $83.32 | $237K |
| May 26, 2026 | Walter Matthew R. | SVP, Chief HR Officer | Option exercise(M) | 9K | — | $0 |
| May 26, 2026 | Walter Matthew R. | SVP, Chief HR Officer | Option exercise(M) | 8K | — | $0 |
| May 26, 2026 | Martha Geoffrey | Chairman and CEO, Director | Option exercise(M) | 85K | — | $0 |
| May 26, 2026 | Wall Brett A. | EVP & Pres Neuroscience | Option exercise(M) | 27K | — | $0 |
| May 26, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | Option exercise(M) | 15K | — | $0 |
| May 26, 2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | Option exercise(M) | 17K | — | $0 |
| May 26, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | Option exercise(M) | 15K | — | $0 |
| May 26, 2026 | Blomquist Denise L. | Chief Accounting Officer | Option exercise(M) | 2K | — | $0 |
| May 26, 2026 | Blomquist Denise L. | Chief Accounting Officer | Option exercise(M) | 2K | — | $0 |
| May 26, 2026 | Martha Geoffrey | Chairman and CEO, Director | Option exercise(M) | 95K | — | $0 |
| May 26, 2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | Option exercise(M) | 19K | — | $0 |
| May 26, 2026 | Wall Brett A. | EVP & Pres Neuroscience | Option exercise(M) | 24K | — | $0 |
| May 1, 2026 | Walter Matthew R. | SVP, Chief HR Officer | Tax withholding(F) | 35 | $80.00 | $3K |
| Apr 28, 2026 | Hogan Randall J | Director | Tax withholding(F) | 207 | $81.90 | $17K |
| Apr 28, 2026 | Donnelly Scott C | Director | Tax withholding(F) | 207 | $81.90 | $17K |
| Apr 28, 2026 | Fonseca Lidia | Director | Tax withholding(F) | 207 | $81.90 | $17K |
| Apr 28, 2026 | Nabel Elizabeth G | Director | Tax withholding(F) | 207 | $81.90 | $17K |
| Apr 28, 2026 | Powell Kendall J | Director | Tax withholding(F) | 207 | $81.90 | $17K |
| Apr 28, 2026 | Blomquist Denise L. | Chief Accounting Officer | Tax withholding(F) | 318 | $81.90 | $26K |
| Apr 28, 2026 | Arnold Craig | Director | Tax withholding(F) | 207 | $81.90 | $17K |
| Apr 28, 2026 | Lofton Kevin E | Director | Tax withholding(F) | 207 | $81.90 | $17K |
| Apr 28, 2026 | Lewis Gregory P | Director | Tax withholding(F) | 207 | $81.90 | $17K |
| Apr 27, 2026 | Hogan Randall J | Director | Grant(A) | 2K | — | $0 |
| Apr 27, 2026 | Jellison William R | Director | Grant(A) | 1K | — | $0 |
| Apr 27, 2026 | Lee Joon Sup | Director | Grant(A) | 2K | — | $0 |
| Apr 27, 2026 | Fonseca Lidia | Director | Grant(A) | 2K | — | $0 |
| Apr 27, 2026 | Groetelaars John P | Director | Grant(A) | 1K | — | $0 |
| Apr 27, 2026 | Nabel Elizabeth G | Director | Grant(A) | 2K | — | $0 |
| Apr 27, 2026 | Donnelly Scott C | Director | Grant(A) | 2K | — | $0 |
| Apr 27, 2026 | Lewis Gregory P | Director | Grant(A) | 2K | — | $0 |
| Apr 27, 2026 | Powell Kendall J | Director | Grant(A) | 2K | — | $0 |
| Apr 27, 2026 | Arnold Craig | Director | Grant(A) | 2K | — | $0 |
| Apr 27, 2026 | Blomquist Denise L. | Chief Accounting Officer | Grant(A) | 2K | — | $0 |
| Apr 27, 2026 | Lofton Kevin E | Director | Grant(A) | 2K | — | $0 |
| Mar 3, 2026 | Pieton Thierry | EVP & Chief Financial Officer | Tax withholding(F) | 3K | $96.71 | $288K |
| Feb 20, 2026 | Blomquist Denise L. | Chief Accounting Officer | Gift(G) | 340 | — | $0 |
| Feb 19, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | Option exercise(M) | 31K | $93.08 | $2.8M |
| Feb 19, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | Option exercise(M) | 20K | $87.76 | $1.7M |
| Feb 19, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | Option exercise(M) | 385 | $80.00 | $31K |
| Feb 19, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | Sell(S) | 2K | $97.86 | $161K |
| Feb 19, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | Sell(S) | 19K | $97.77 | $1.9M |
| Feb 19, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | Sell(S) | 31K | $97.66 | $3.0M |
| Feb 19, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | Sell(S) | 385 | $97.82 | $38K |
| Feb 19, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | Option exercise(M) | 31K | — | $0 |
| Feb 19, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | Option exercise(M) | 20K | — | $0 |
| Feb 19, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | Option exercise(M) | 385 | — | $0 |
| Feb 19, 2026 | Kiil Harry Skip | EVP & President Cardiovascular | Sell(S) | 668 | $97.83 | $65K |
| Jan 29, 2026 | Blomquist Denise L. | Chief Accounting Officer | Tax withholding(F) | 148 | $101.00 | $15K |
| Dec 15, 2025 | Martha Geoffrey | Chairman and CEO, Director | Tax withholding(F) | 2K | $99.87 | $156K |
| Dec 15, 2025 | Marinaro Michael | EVP, Pres MedSurg and Americas | Tax withholding(F) | 1K | $99.87 | $137K |
| Dec 15, 2025 | Wall Brett A. | EVP & Pres Neuroscience | Tax withholding(F) | 439 | $99.87 | $44K |
| Dec 5, 2025 | Kiil Harry Skip | EVP & President Cardiovascular | Tax withholding(F) | 2K | $101.36 | $173K |
| Nov 20, 2025 | Blomquist Denise L. | Chief Accounting Officer | Gift(G) | 170 | — | $0 |
| Nov 19, 2025 | Smith Gregory L | EVP Global Ops & Supply Chain | Sell(S) | 24K | $101.93 | $2.5M |
| Nov 19, 2025 | Smith Gregory L | EVP Global Ops & Supply Chain | Sell(S) | 2K | $101.99 | $198K |
| Nov 19, 2025 | Smith Gregory L | EVP Global Ops & Supply Chain | Sell(S) | 2K | $102.03 | $204K |
| Nov 19, 2025 | Smith Gregory L | EVP Global Ops & Supply Chain | Sell(S) | 825 | $102.04 | $84K |
| Nov 19, 2025 | Smith Gregory L | EVP Global Ops & Supply Chain | Sell(S) | 325 | $102.06 | $33K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Medtronic plc, SEC CIK 0001613103. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under MDT and shows every filing by that issuer. Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-12. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for MDT